50 Shades of Green: A Climate Group Podcast
What was said
We find in it AstraZeneca has electrified 80% of its global fleet of 22,000 vehicles. And so there's a case study in there on exactly how AstraZeneca has done that and the work and the kind of internal structures needed for that level of ambition.
“We find in it AstraZeneca has electrified 80% of its global fleet of 22,000 vehicles. And so there's a case study in there on exactly how AstraZeneca has done that and the work and the kind of internal structures needed for that level of ambition.”
Richard Parker50 Shades of Green: A Climate Group PodcastView
“The change from a disposable to a reusable product was really the reason for that was driven by AstraZeneca. And it was around a sustainability decision to move to that reusable product.”
Richard Parker50 Shades of Green: A Climate Group PodcastView
“through changing that protocol where people have got used to a disposable device and then had to move to a reusable one, that was quite a significant change. And how could we, through inclusive design approaches, redesign packaging to make that transition more user-friendly for people?”
Richard Parker50 Shades of Green: A Climate Group PodcastView
“we also have our own GLP-1 medicine development. The drugs in the market today are injectable. And we have what is an oral small molecule GLP-1. So not a peptide GLP-1, but a small molecule oral GLP-1. And we will be presenting soon the phase two data from that and expect to move that into phase three.”
Richard Parker50 Shades of Green: A Climate Group PodcastView
What this signalsWhat leaders say on podcasts often shows their current priorities.
podcast-companystrategicInitiativeGet every podcast signal for AstraZeneca and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AstraZeneca this week?”
The Signal API returns podcast signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full podcast-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f2ffc18d-6096-51e0-9696-88b28d7f0e03 returns this record as JSON. POST /v1/companies/enrich returns every signal for astrazeneca.com.
{
"signal_id": "f2ffc18d-6096-51e0-9696-88b28d7f0e03",
"signal_type": "podcast-company",
"signal_subtype": "strategicInitiative",
"detected_at": "2026-08-24T10:25:03+00:00",
"company": {
"name": "AstraZeneca",
"domain": "astrazeneca.com"
},
"data": {
"is_ad": false,
"quotes": [
"We find in it AstraZeneca has electrified 80% of its global fleet of 22,000 vehicles. And so there's a case study in there on exactly how AstraZeneca has done that and the work and the kind of internal structures needed for that level of ambition.",
"The change from a disposable to a reusable product was really the reason for that was driven by AstraZeneca. And it was around a sustainability decision to move to that reusable product.",
"through changing that protocol where people have got used to a disposable device and then had to move to a reusable one, that was quite a significant change. And how could we, through inclusive design approaches, redesign packaging to make that transition more user-friendly for people?",
"we also have our own GLP-1 medicine development. The drugs in the market today are injectable. And we have what is an oral small molecule GLP-1. So not a peptide GLP-1, but a small molecule oral GLP-1. And we will be presenting soon the phase two data from that and expect to move that into phase three."
],
"timing": "in_progress",
"speaker": "Richard Parker",
"evidence": "We find in it AstraZeneca has electrified 80% of its global fleet of 22,000 vehicles. And so there's a case study in there on exactly how AstraZeneca has done that and the work and the kind of internal structures needed for that level of ambition.",
"headline": "AstraZeneca · strategicInitiative · in_progress (2026-08)",
"episode_id": "58624812736",
"event_date": "2026-08",
"episode_url": "https://shows.acast.com/50-shades-of-green/episodes/it-doesnt-have-to-be-perfect-the-ev-debate",
"podcast_name": "50 Shades of Green: A Climate Group Podcast",
"published_at": "2026-08-06",
"episode_title": "It doesn't have to be perfect: The EV Debate",
"date_confidence": "exact",
"speaker_relation": "third_party",
"transcript_source": "transcript",
"recorded_at_estimate": "2026-08-03"
}
}
curl https://signals.autobound.ai/v1/signals/f2ffc18d-6096-51e0-9696-88b28d7f0e03 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"astrazeneca.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.